The selection of vaccine sceptic Robert F Kennedy Jr by US President-elect Donald Trump to head the Department of Health and ...

With the S&P 500 up over 25% year-to-date, it’s safe to assume the index will finish the year in positive territory for the eighth time in the past decade. The week was full of intriguing political ...

More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F. Kennedy Jr. to be the next secretary of the Department of Health and Human ...

Although it is seeing a downturn in sales and profits, German biotech BioNTech (Nasdaq: BNTX) is continuing to acquire assets ...

According to CNN, the stocks of leading vaccine manufacturers plummeted on Thursday after President-elect Donald Trump ...

According to CNN, the shares of leading vaccine manufacturers plummeted on Thursday after President-elect Donald Trump ...

According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two years now, the US government has been running its public vaccination campaign ...

Pfizer also provides medicines and vaccines in various therapeutic areas, such as: Pneumococcal disease, meningococcal ...

Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.